GSK/Corixa Bexxar Nuclear Pharmacy Training Kicks Off With FDA Approval

 
• By The Pink Sheet

GlaxoSmithKline and Corixa's Bexxar nuclear pharmacy training program could help encourage faster uptake of the oncologic than Idec's Zevalin

More from Archive

More from Pink Sheet